Clinical Trial Update: Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial in advanced non-small cell lung cancer compares paclitaxel/carboplatin followed by gefitinib versus paclitaxel/carboplatin alone; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gefitinib (Iressa) (gefitinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Asan Medical Center | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED